Previous 10 | Next 10 |
PARSIPPANY, NJ, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc.’s subsidiary, Interpace BioPharma Inc. (“Interpace”, “Interpace BioPharma” or the “Company”) today announced that it has entered into a partnership agre...
PARSIPPANY, NJ, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) today announced that the Company will present at the upcoming 21 st Annual Global Investment Conference, sponsored by H.C. ...
MINNEAPOLIS, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc., (NASDAQ: POAI) (“Predictive Oncology ” or “the Company”) an artificial intelligence (AI) and data-driven functional precision medicine company with the mission of improving the standard of c...
Start Time: 08:30 End Time: 09:16 Interpace Diagnostics Group, Inc. (IDXG) Q2 2019 Earnings Conference Call August 13, 2019, 08:30 AM ET Company Participants Jack Stover - President and CEO Jim Early - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann ...
Interpace Diagnostics (NASDAQ: IDXG ): Q2 GAAP EPS of -$0.14 misses by $0.07 . More news on: Interpace Diagnostics Group, Inc., Earnings news and commentary, Stocks on the move, Consumer stocks news, , Read more ...
Second Quarter Revenue Grew 14% Over the Prior Year and 19% Year to Date Over the Prior Year Acquired Growing BioPharma Services Business Net Revenue Guidance Increased Conference Call and Webcast Tuesday August 13, 2019 at 8:30 am ET Parsippany, NJ, Aug. 13, 2019 (GLOBE NE...
PARSIPPANY, NJ, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it will report its second quarter 2019 financial results on Tuesday, August 13, 2019 at 8:30 a.m. ET. Interpace will host a conference call and webcast to discuss the Comp...
In Network Access for More Than 6 Million Members PARSIPPANY, NJ, July 31, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has contracted with Blue Cross Blue Shield (BCBS) of Michigan, a not-for-profit independent member of the Blue ...
Four Million Members Gain in-Network Access PARSIPPANY, NJ, July 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has entered in to a contract with Blue Shield of California, a not-for-profit independent member of the Blue Cross Blue...
Interpace Diagnostics Group (NASDAQ: IDXG ) has reached an agreement with SelectHealth to provide its proprietary thyroid cancer assays, ThyGeNEXT and ThyraMIR to latter’s more than 850,000 members in Utah and Idaho. More news on: Interpace Diagnostics Group, Inc., Healt...
News, Short Squeeze, Breakout and More Instantly...
Interpace Biosciences Inc. Company Name:
IDXG Stock Symbol:
NASDAQ Market:
Interpace Biosciences Inc. Website:
PARSIPPANY, NJ, June 04, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics ® , a subsidiary of Interpace Biosciences ® (OTCQX: IDXG), is proud to announce that new data demonstrating the application of advanced sequencing technologies in pancreatic cancer was published as an e-ab...
PARSIPPANY, NJ, May 09, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the first quarter ended March 31, 2024 and provided a business and financial update. First quarter Net ...
GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...